• 九游会j9网站首页,j9九游会首页登录,j9九游会ag真人官网

    您好,欢迎光临九游会j9网站首页商城!
    服务热线:400 680 0892
    新闻资讯 News

    BioXcell新品推荐——InVivoMAb anti-mouse CD172a (SIRPα)单克隆抗体

    2021-04-29
    浏览次数: 40

    研发背景

    P84单克隆抗体,也被称为CD172a抗体,可与信号调节蛋白α(SIRPα)反应SIRPα蛋白是I型跨膜糖蛋白,在单核细胞巨噬细胞和树突细胞均有表达。此外,在神经元和中枢神经系统的一些其他组织也发现有SIRPα蛋白的表达。其配体CD47在多种细胞均有表达

     

    SIRPαCD47参与调节树突细胞介导的T细胞活化中性粒细胞迁移和吞噬等过程SIRPα蛋白可在巨噬细胞的细胞膜上进行横向扩散并在吞噬性突触中积累,与CD47结合后,抑制巨噬细胞的吞噬作用。

     

    研究结果表明,使用anti-SIRPα抗体阻断SIRPαCD47相互作用,可抑制小鼠体内肿瘤形成。此外,P84CD172a)单克隆抗体在体内和体外具有中和活性。

     

    BioXcell最新推出InVivoMAb anti-mouse CD172a (SIRPα)单克隆抗体,助力肿瘤免疫检查点研究。



    产品信息:

    产品货号 BE0322
    产品名称 InVivoMAb anti-mouse CD172a (SIRPα)
    规格 1mg,5mg,25mg, 50mg, 100mg
    克隆号 P84
    同种型(Isotype) Rat IgG1, κ
    免疫原(Immunogen) Mouse brain membrane protein
    成分(Formulation) PBS, pH 7.0  
    Contains no stabilizers or preservatives
    内毒素(Endotoxin) <2EU/mg (<0.002EU/μg)
    Determined by LAL gel clotting assay
    纯度(Purity) >95%
    Determined by SDS-PAGE
    无菌(Sterility) 0.2 μM filtered
    生产(Production) Purified from tissue culture supernatant in an animal free facility
    纯化(Purification) Protein A
    保存(Storage) Undiluted at 4°C in the dark
    应用(Reported Applications) In vivo SIRPα blocking
    In vitro SIRPα blocking
    Western blot


    Application References:

    Yanagita, T., et al. (2017). 'Anti-SIRPalpha antibodies as a potential new tool for cancer immunotherapy.' JCI Insight 2(1): e89140. 

    Koskinen, C., et al. (2013). 'Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein alpha (SIRPalpha) signaling.' J Biol Chem 288(41): 29333-29344. 

    Teraoka, Y., et al. (2013). 'Expression of recipient CD47 on rat insulinoma cell xenografts prevents macrophage-mediated rejection through SIRPalpha inhibitory signaling in mice.' PLoS One 8(3): e58359. 

    Zen, K., et al. (2013). 'Inflammation-induced proteolytic processing of the SIRPalpha cytoplasmic ITIM in neutrophils propagates a proinflammatory state.' Nat Commun 4: 2436.

    Lundberg, P., et al. (2007). 'Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction.' Biochem Biophys Res Commun 352(2): 444-448. 

    Oldenborg, P. A., et al. (2001). 'CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.' J Exp Med 193(7): 855-862.

     

     九游会j9网站首页有限公司 


    全国服务热线: 4006-800-892            邮箱: market@qckc0531.com  


    深圳: 0755-26755892      北京: 010-88594029       上海: 021-34613729       


    广州: 18024516375        香港: 852-69410778  


    代理品牌网站: www.nbs-bio.com 

    自主品牌网站: www.neobiosescience.net 


    糖型分析网站:www.glycan-analysis.com 


    分享到:
    关注欣博盛公众号
    Copyright ©2021 - 2023 深圳九游会j9网站首页有限公司
      网站地图
    犀牛云提供企业云服务